Vaccination strategies for patients under monoclonal antibody and other biological treatments: an updated comprehensive review based on EMA authorisations to January 2024

Monoclonal antibodies (mAbs) and other biological agents are being increasingly approved in the last years with very different indications. Their highly heterogeneous immunosuppressive effects, mechanisms of action and pharmacokinetics require comprehensive individualized vaccination schedules. Vacc...

Full description

Bibliographic Details

Published in:	Expert review of vaccines Vol. 23; no. 1; pp. 887 - 910
Main Authors:	Rivera-Izquierdo, Mario, Morales-Portillo, Arturo, Guerrero-Fernández de Alba, Inmaculada, Fernández-Martínez, Nicolás Francisco, Schoenenberger-Arnaiz, Joan Antoni, Barranco-Quintana, José Luis, Valero-Ubierna, Carmen
Format:	Journal Article
Language:	English
Published:	England Taylor & Francis Group 31.12.2024
Subjects:	Biologic therapy biologics immunosuppression mAbs nirsevimab vaccine vaccine biologics mabs immunosuppression vaccine schedule nirsevimab Biologic therapy
ISSN:	1476-0584, 1744-8395, 1744-8395
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!